Results 1 to 10 of about 41,043 (214)

COVID-19 Vaccination Strategy and Evidence in Korea. [PDF]

J Korean Med Sci
Hwang YH, Park WB.
europepmc   +1 more source

Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in Indonesia: A Single-Blinded Randomized Controlled Trial. [PDF]

Vaccines (Basel)
Putri ND, Zhafira AS, Wicaksana P, Satari HI, Fadlyana E, Safitri V, Nurlailah N, Putri ES, Putri N, Iriyani DS, Ulina YS, Aprilia F, Pratama E, Nethalia I, Yustisiana R, Aini EQ, Fajarani R, Susilo A, Karyanti MR, Prayitno A, Sukandar H, Watts E, Mazarakis N, Multihartina P, Setiawaty V, Pangesti KNA, Indrati AR, Sundoro J, Handayani DO, Kartasasmita CB, Hadinegoro SR, Mulholland K.   +31 more
europepmc   +1 more source

Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines. [PDF]

Nat Commun
Chen W, Tompkins KR, Windsor IW, Martinez LT, Ramos M, Li W, Shrivastava S, Rajput S, Chang JS, Sahasrabudhe P, Fennell KF, McLellan TJ, West GM, Dizon KP, Yam A, Mitra S, Saha S, Sharaf D, McKeen AP, Cadima CI, Muik A, Swanson W, Munoz Moreno R, Mendoza Daroca P, Sahin U, Anderson AS, Wu H, Swanson KA, Modjarrad K.   +28 more
europepmc   +1 more source

T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children. [PDF]

Open Forum Infect Dis
Vogler I, Renken S, Hilker R, Lui BG, Finlayson A, Gurtman A, Sabharwal C, Kitchin N, Lockhart S, Gruber WC, Jansen KU, Swanson KA, Türeci Ö, Şahin U.   +13 more
europepmc   +1 more source

Effectiveness of COVID-19 Vaccination in Reducing Severity Among SARS-CoV-2 Infected Patients: A Prospective Study From Iraq. [PDF]

Health Sci Rep
Al-Obaidi AH, Ibrahim MM, Al-Qaseer AHAM.   +2 more
europepmc   +1 more source

Low reactogenicity and high tumour antigen expression from mRNA-LNPs with membrane-destabilizing zwitterionic lipids. [PDF]

Nat Biomed Eng
Zhao Y, Li R, Liu P, Wang J, Cui Y, Ma Y, Cao Z, Cui M, Luozhong S, Wagner E, Laflin A, Ding Y, Hu Y, Tian Z, Tang C, Cai S, Young H, Liu D, Gu W, Bailey S, Jiang S.   +20 more
europepmc   +1 more source

A biomimetic model composed of injectable 3D muscle-like tissue, stromal and immune cells for recapitulating the rapid immune signature predictive of mRNA vaccine immunogenicity. [PDF]

Front Immunol
Etna MP, Fuoco C, Severa M, Ricci D, Sinigaglia A, Lucca C, Cairo G, Bottazzi B, Garlanda C, Palamara AT, Barzon L, Gargioli C, Coccia EM.   +12 more
europepmc   +1 more source

Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study. [PDF]

Hum Vaccin Immunother
Smolinski M, Chew JL, Constantinescu C, Buchan CA, Burton C, Carignan A, Castellucci LA, Suresh S, McConnell A, Morris SK, Naus M, Pernica JM, Pham-Huy A, Piche-Renaud PP, Sadarangani M, Top KA, Cowan J, Special Immunization Clinic Network investigators.   +17 more
europepmc   +1 more source

Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation. [PDF]

Antibodies (Basel)
Benucci M, Cioffi E, Li Gobbi F, Cassarà EAM, Terenzi R, Russo E, Grossi V, Lari B, Infantino M, Manfredi M.   +9 more
europepmc   +1 more source

Body composition measurement and diabetes - A new perspective on development of antibodies after SARS-CoV-2 booster vaccination. [PDF]

J Diabetes Metab Disord
Van Baal L, Tan S, Fuhrer D, Reinold J, Dittmer U, Fiedler M.   +5 more
europepmc   +1 more source